财中社1月23日电 金斯瑞生物科技(01548)发布公告,公司联营企业传奇生物科技股份有限公司在截至2024年12月31日的季度内,CARVYKTI?的初步销售额约为3.34亿美元。该销售额基于与Janssen Inc.于2017年12月21日签订的合作及许可协议中提供的信息,传奇生物和公司均未独立核实该销售数字的准确性。 公告中指出,销售数据是基于截至公告日期的可获得信息,传奇生物的合并经营报表...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.